Lisata Therapeutics (LSTA) Competitor Comparison
We are evaluating the key criteria listed to compare Lisata Therapeutics (LSTA) against its competitors in the Biotechnology industry.
Market Capitalization
318 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
101 / 337Free Cashflow
122 / 352Quick Ratio
74 / 357Earnings per Share
240 / 359Dividend yield
0 / 6Total Cash
254 / 358Performance 3 years
252 / 368Performance 5 years
294 / 368Performance 10 years
343 / 368Linearity 3 years
239 / 368Linearity 5 years
252 / 368Linearity 10 years
315 / 368Total Rank
13 / 368Dividend Rank
44 / 368Valuation Rank
214 / 368Piotroski Rank
157 / 368Muliplier Rank
17 / 368Market Capitalization - LSTA ranking 318 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.